Foresight Solar Fund

Edison Investment Research is terminating coverage on Foresight Solar Fund (FSFL). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Equities

Equities by Sector

Sectors

Thematics

Latest

Hybrid Air Vehicles – Redefining air travel and air freight

The humanoid revolution walking your way: How robots are stepping out of science fiction

From gold to gold miners: Extracting higher returns in the current bull run

Audiovisual

Latest

Herantis Pharma – executive interview

Take on Trusts – April 2025

KEFI Gold and Copper – executive interview

About Edison

About Edison

Careers

Foresight Solar Fund (LSE: FSFL)

Latest Insights

Foresight Solar Fund (LSE: FSFL) H124 results

Edison Growth Conference panel – Decarbonisation

Foresight Solar Fund – executive interview

Foresight Solar Fund — Optimising capital allocation

Sector

Research

Foresight Solar Fund — Powered by merchant exposure

Foresight Solar Fund — Solar energy: the future is here

Foresight Solar Fund — Growth ambitions

Foresight Solar Fund — Growth ambitions

Foresight Solar Fund — Powered by merchant exposure

Foresight Solar Fund — Solar energy: the future is here

US small-cap equities – Time to shine?

Emerging markets – Worthy of consideration

Dynam Capital at the 2024 Vietnam ESG Conference

UK stock market – Scope for further upside in UK large-cap stocks

Listed private equity – Performing a balancing act

European equities

Listed Private Equity

Vietnamese equities: Due a comeback?

Investment companies: Latin America is worthy of consideration

IPO apocalypse

ESG, moving beyond the box tick

The case for US capital markets

Value Investing: Living with the reality, waiting for the inevitable

Illuminator: August Update

Post Woodford- A spotlight on smaller company liquidity

How to buy and sell investment trusts

Types of investment trusts

Deutsche Börse Eigenkapitalforum 2014 Research Guide

Investment Trusts Quarterly: Biotechnology & healthcare trusts

Investment Trusts Quarterly: Growth and income